Autophagy pathways in eukaryotic cells mediate the turnover of a diverse set of cytoplasmic components, including damaged organelles and abnormal protein aggregates. Autophagy-mediated degradation is highly regulated, and defects in these pathways have been linked to a number of human disorders. The Atg1 protein kinase appears to be a key site of this control and is targeted by multiple signaling pathways to ensure the appropriate autophagic response to changing environmental conditions. Despite the importance of this kinase, relatively little is known about the molecular details of Atg1 activation. In this study we show that Atg13, an evolutionarily conserved regulator of Atg1, promotes the formation of a specific Atg1 self-interaction in the budding yeast, Saccharomyces cerevisiae. The appearance of this Atg1-Atg1 complex is correlated with the induction of autophagy, and conditions that disrupt this complex result in diminished levels of both autophagy and Atg1 kinase activity. Moreover, the addition of a heterologous dimerization domain to Atg1 resulted in elevated kinase activity both in vivo and in vitro. The formation of this complex appears to be an important prerequisite for the subsequent autophosphorylation of Thr-226 in the Atg1 activation loop. Previous work indicates that this modification is necessary and perhaps sufficient for Atg1 kinase activity. Interestingly, this Atg1 self-association does not require Atg17, suggesting that this second conserved regulator might activate Atg1 in a manner mechanistically distinct from that of Atg13. In all, this work suggests a model whereby this self-association stimulates the autophosphorylation of Atg1 within its activation loop.The term autophagy refers to a collection of membrane-trafficking pathways in eukaryotic cells that are responsible for the degradation of cytoplasmic protein and organelles (1-3). During this transport, these cytoplasmic materials are encapsulated within a membrane-bound intermediate and targeted to the lysosome for degradation (4). Defects in these transport pathways have been linked to a variety of human ailments including specific cancers, Crohn disease, and neurological disorders such as Huntington disease (5-8). In many of these conditions autophagy is being considered as a potential point of therapeutic intervention (9 -12). It is, therefore, critical that we develop a thorough understanding of the proteins involved in these transport pathways and the manner in which these degradative activities are regulated.The basic machinery of autophagy is evolutionarily conserved and has been found in all eukaryotic cells (13). The best understood of these degradative pathways is the nonspecific macroautophagy that was initially characterized at the molecular level in the budding yeast, Saccharomyces cerevisiae (2,14,15). This pathway, like most autophagy-based transport, is highly regulated, and the Atg1 protein kinase appears to be a key element of this control (16 -18). This enzyme and its associated partners are targeted by multiple...